Welcome to LookChem.com Sign In|Join Free

CAS

  • or
METHYL 3-IODO-1H-INDOLE-6-CARBOXYLATE, a chemical compound with the molecular formula C10H8INO2, is an ester derivative of indole, a heterocyclic aromatic organic compound. It is recognized for its diverse applications and plays a crucial role in the development of various types of drugs and chemicals.

850374-98-0

Post Buying Request

850374-98-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

850374-98-0 Usage

Uses

Used in Pharmaceutical Industry:
METHYL 3-IODO-1H-INDOLE-6-CARBOXYLATE is used as a chemical intermediate for the synthesis of various pharmaceuticals. It contributes to the development of new compounds with potential therapeutic properties, enhancing the range of treatments available for various medical conditions.
Used in Agrochemical Industry:
In the agrochemical sector, METHYL 3-IODO-1H-INDOLE-6-CARBOXYLATE serves as an intermediate in the synthesis of agrochemicals. It aids in the creation of new compounds with pesticidal properties, improving crop protection and contributing to more efficient agricultural practices.
Used in Research and Development:
METHYL 3-IODO-1H-INDOLE-6-CARBOXYLATE is utilized in research and development settings to explore its potential applications in creating new compounds. Its unique structure and properties make it a valuable asset in the discovery and innovation of novel therapeutic and pesticidal agents.

Check Digit Verification of cas no

The CAS Registry Mumber 850374-98-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,0,3,7 and 4 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 850374-98:
(8*8)+(7*5)+(6*0)+(5*3)+(4*7)+(3*4)+(2*9)+(1*8)=180
180 % 10 = 0
So 850374-98-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H8INO2/c1-14-10(13)6-2-3-7-8(11)5-12-9(7)4-6/h2-5,12H,1H3

850374-98-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name METHYL 3-IODO-1H-INDOLE-6-CARBOXYLATE

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:850374-98-0 SDS

850374-98-0Relevant articles and documents

Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain

Luo, Guanglin,Chen, Ling,Easton, Amy,Newton, Amy,Bourin, Clotilde,Shields, Eric,Mosure, Kathy,Soars, Matthew G.,Knox, Ronald J.,Matchett, Michele,Pieschl, Rick L.,Post-Munson, Debra J.,Wang, Shuya,Herrington, James,Graef, John,Newberry, Kimberly,Sivarao, Digavalli V.,Senapati, Arun,Bristow, Linda J.,Meanwell, Nicholas A.,Thompson, Lorin A.,Dzierba, Carolyn

, p. 831 - 856 (2019/01/21)

3-Aryl-indole and 3-aryl-indazole derivatives were identified as potent and selective Nav1.7 inhibitors. Compound 29 was shown to be efficacious in the mouse formalin assay and also reduced complete Freund's adjuvant (CFA)-induced thermal hyper

RORγ MODULATORS

-

Page/Page column 32-33, (2018/04/13)

The invention provides an RORγ receptor agonist comprising a compound of formula (I), wherein the variables are as defined herein. These compounds are analogous to known RORγ receptor antagonists. The invention further provides a method of activating -the nuclear receptor RORγ, comprising -contacting the RORγ with an effective amount or concentration of a compound of the invention; and a method of treating cancer in a patient, comprising administering to the patient an effective dose of a compound of the invention.

ACYL SULFONAMIDE NaV1.7 INHIBITORS

-

Page/Page column 20, (2017/11/15)

The present disclosure relates to compounds of formula I which inhibit NaV1.7, and include pharmaceutically acceptable salts, compositions comprising such compounds, and methods using and making such compounds and compositions.

Design and Synthesis of 2,2′-Diindolylmethanes to Selectively Target Certain G-Quadruplex DNA Structures

Livendahl, Madeleine,Jamroskovic, Jan,Ivanova, Svetlana,Demirel, Peter,Sabouri, Nasim,Chorell, Erik

supporting information, p. 13004 - 13009 (2016/09/09)

G-quadruplex (G4) structures carry vital biological functions, and compounds that selectively target certain G4 structures have both therapeutic potential and value as research tools. Along this line, 2,2′-diindolylmethanes have been designed and synthesi

five Yuan fragrance heterocyclic structure containing the anti-hepatitis c compound and its preparation and use

-

Paragraph 0125; 0130-0131, (2016/11/21)

The invention discloses an anti-HCV (hepatitis C) compound containing a five-membered heteroaromatic ring structure, as well as a preparation method and applications thereof. The compound has a structure shown as the formula I, the compound has excellent anti-HCV virus activity, can be used for preparing anti-HCV drugs, the prepared drugs can be applied by adopting oral administration, intravenous injection or intramuscular injection.

Construction of Cyclopenta[b]indol-1-ones by a Tandem Gold(I)-Catalyzed Rearrangement/Nazarov Reaction and Application to the Synthesis of Bruceolline H

Scarpi, Dina,Petrovi?, Martina,Fiser, Béla,Gómez-Bengoa, Enrique,Occhiato, Ernesto G.

supporting information, p. 3922 - 3925 (2016/08/16)

A tandem gold(I)-catalyzed rearrangement/Nazarov reaction of enynyl acetates which efficiently provides cyclopenta[b]indol-1-ones as useful precursors for the synthesis of natural and bioactive compounds is described. The synthetic potential of the method

Novel inverse binding mode of indirubin derivatives yields improved selectivity for DYRK kinases

Myrianthopoulos, Vassilios,Kritsanida, Marina,Gaboriaud-Kolar, Nicolas,Magiatis, Prokopios,Ferandin, Yoan,Durieu, Emilie,Lozach, Olivier,Cappel, Daniel,Soundararajan, Meera,Filippakopoulos, Panagis,Sherman, Woody,Knapp, Stefan,Meijer, Laurent,Mikros, Emmanuel,Skaltsounis, Alexios-Leandros

supporting information, p. 22 - 26 (2013/03/13)

DYRK kinases are involved in alternative pre-mRNA splicing as well as in neuropathological states such as Alzheimer's disease and Down syndrome. In this study, we present the design, synthesis, and biological evaluation of indirubins as DYRK inhibitors wi

Catalytic anomeric aminoalkynylation of unprotected aldoses

Kimura, Yasuaki,Ito, Soichi,Shimizu, Yohei,Kanai, Motomu

supporting information, p. 4130 - 4133 (2013/09/12)

A copper(I)-catalyzed anomeric aminoalkynylation reaction of unprotected aldoses was realized. Use of an electron-deficient phosphine ligand, boric acid to stabilize the iminium intermediate, and a protic additive (IPA) to presumably enhance reversible carbohydrate-boron complexation were all essential for efficient conversion. The reaction proceeded well even with a natural disaccharide substrate, suggesting that the developed catalytic reaction could be useful for the synthesis of glycoconjugates with minimum use of protecting groups.

Amino-zinc-ene-enolate cyclization: A short access to cis-3-substituted prolino-homotryptophane derivatives

Mothes, Celine,Lavielle, Solange,Karoyan, Philippe

, p. 6706 - 6710 (2008/12/22)

(Chemical Equation Presented) Proline chimeras are useful tools for medicinal chemistry and/or biological applications. The asymmetric synthesis of cis-3-substituted prolines can be easily achieved via amino-zinc-ene-enolate cyclization followed by transm

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 850374-98-0